Anchored multiplex PCR for targeted next-generation sequencing (original) (raw)

• Technical Report
• Published: 10 November 2014
• Matthew Liebers1,
• Boryana Zhelyazkova1,
• Yi Cao1,
• Divya Panditi1,
• Kerry D Lynch1,
• Juxiang Chen1,3,
• Hayley E Robinson1,
• Hyo Sup Shim1,4,
• Juliann Chmielecki5,
• William Pao5,
• Jeffrey A Engelman6,
• A John Iafrate1,6 &
• …
• Long Phi Le1,6

Nature Medicine volume 20, pages 1479–1484 (2014)Cite this article

• 29k Accesses
• 669 Citations
• 44 Altmetric
• Metrics details

Subjects

Abstract

We describe a rapid target enrichment method for next-generation sequencing, termed anchored multiplex PCR (AMP), that is compatible with low nucleic acid input from formalin-fixed paraffin-embedded (FFPE) specimens. AMP is effective in detecting gene rearrangements (without prior knowledge of the fusion partners), single nucleotide variants, insertions, deletions and copy number changes. Validation of a gene rearrangement panel using 319 FFPE samples showed 100% sensitivity (95% confidence limit: 96.5–100%) and 100% specificity (95% confidence limit: 99.3–100%) compared with reference assays. On the basis of our experience with performing AMP on 986 clinical FFPE samples, we show its potential as both a robust clinical assay and a powerful discovery tool, which we used to identify new therapeutically important gene fusions: _ARHGEF2_-NTRK1 and _CHTOP_-NTRK1 in glioblastoma, _MSN_-ROS1, TRIM4-BRAF, VAMP2-NRG1, TPM3-NTRK1 and RUFY2-RET in lung cancer, FGFR2-CREB5 in cholangiocarcinoma and PPL-NTRK1 in thyroid carcinoma. AMP is a scalable and efficient next-generation sequencing target enrichment method for research and clinical applications.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

References

1. Mamanova, L. et al. Target-enrichment strategies for next-generation sequencing. Nat. Methods 7, 111–118 (2010).
   Article CAS Google Scholar
2. Meyerson, M., Gabriel, S. & Getz, G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 11, 685–696 (2010).
   Article CAS Google Scholar
3. Kwak, E.L. et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363, 1693–1703 (2010).
   Article CAS Google Scholar
4. Bergethon, K. et al. ROS1 rearrangements define a unique molecular class of lung cancers. J. Clin. Oncol. 30, 863–870 (2012).
   Article CAS Google Scholar
5. Drilon, A. et al. Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas. Cancer Discov. 3, 630–635 (2013).
   Article CAS Google Scholar
6. Heuckmann, J.M. et al. Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants. Clin. Cancer Res. 18, 4682–4690 (2012).
   Article CAS Google Scholar
7. Crystal, A.S. & Shaw, A.T. Variants on a theme: a biomarker of crizotinib response in ALK-positive non-small cell lung cancer? Clin. Cancer Res. 18, 4479–4481 (2012).
   Article CAS Google Scholar
8. Takeuchi, K. et al. RET, ROS1 and ALK fusions in lung cancer. Nat. Med. 18, 378–381 (2012).
   Article CAS Google Scholar
9. Frohman, M.A., Dush, M.K. & Martin, G.R. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85, 8998–9002 (1988).
   Article CAS Google Scholar
10. Zheng, Z. et al. Titration-free 454 sequencing using Y adapters. Nat. Protoc. 6, 1367–1376 (2011).
    Article CAS Google Scholar
11. Zheng, Z. et al. Titration-free massively parallel pyrosequencing using trace amounts of starting material. Nucleic Acids Res. 38, e137 (2010).
    Article Google Scholar
12. Neiman, M. et al. Library preparation and multiplex capture for massive parallel sequencing applications made efficient and easy. PLoS ONE 7, e48616 (2012).
    Article CAS Google Scholar
13. Wang, T., Yu, D. & Lamb, M.L. Trk kinase inhibitors as new treatments for cancer and pain. Expert Opin. Ther. Pat. 19, 305–319 (2009).
    Article CAS Google Scholar
14. Dias-Santagata, D. et al. Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine. EMBO Mol. Med. 2, 146–158 (2010).
    Article Google Scholar
15. Chmielecki, J. et al. Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer. Nucleic Acids Res. 38, 6985–6996 (2010).
    Article CAS Google Scholar
16. Aird, D. et al. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 12, R18 (2011).
    Article CAS Google Scholar
17. Oyola, S.O. et al. Optimizing Illumina next-generation sequencing library preparation for extremely AT-biased genomes. BMC Genomics 13, 1 (2012).
    Article CAS Google Scholar
18. Chevet, E., Lemaitre, G. & Katinka, M.D. Low concentrations of tetramethylammonium chloride increase yield and specificity of PCR. Nucleic Acids Res. 23, 3343–3344 (1995).
    Article CAS Google Scholar
19. Tewhey, R. et al. Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat. Biotechnol. 27, 1025–1031 (2009).
    Article CAS Google Scholar
20. Turner, E.H. et al. Massively parallel exon capture and library-free resequencing across 16 genomes. Nat. Methods 6, 315–316 (2009).
    Article CAS Google Scholar
21. Beltran, H. et al. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity. Eur. Urol. 63, 920–926 (2013).
    Article CAS Google Scholar
22. Clark, M.J. et al. Performance comparison of exome DNA sequencing technologies. Nat. Biotechnol. 29, 908–914 (2011).
    Article CAS Google Scholar
23. Yousem, S.A. et al. Pulmonary Langerhans cell histiocytosis: profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 143, 1679–1684 (2013).
    Article CAS Google Scholar
24. Do, H. et al. Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates. Clin. Chem. 59, 1376–1383 (2013).
    Article CAS Google Scholar
25. Johansson, H. et al. Targeted resequencing of candidate genes using selector probes. Nucleic Acids Res. 39, e8 (2011).
    Article CAS Google Scholar
26. Varley, K.E. & Mitra, R.D. Nested Patch PCR enables highly multiplexed mutation discovery in candidate genes. Genome Res. 18, 1844–1850 (2008).
    Article CAS Google Scholar
27. Donner, A. & Rotondi, M.A. Sample size requirements for interval estimation of the kappa statistic for interobserver agreement studies with a binary outcome and multiple raters. Int. J. Biostat. 6, 31 (2010).
    Article Google Scholar
28. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
    Article Google Scholar
29. Kent, W.J. BLAT–the BLAST-like alignment tool. Genome Res. 12, 656–664 (2002).
    Article CAS Google Scholar
30. Koboldt, D.C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568–576 (2012).
    Article CAS Google Scholar
31. Untergasser, A. et al. Primer3—new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).
    Article CAS Google Scholar

Download references

Acknowledgements

This study was supported by a US National Institutes of Health grant (R21CA161590) to A.J.I. and a postdoctoral fellowship from the Swedish Research Council (350-2012-368) to Z.Z.

Author information

Authors and Affiliations

1. Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA
   Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D Lynch, Juxiang Chen, Hayley E Robinson, Hyo Sup Shim, A John Iafrate & Long Phi Le
2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
   Zongli Zheng
3. Department of Neurosurgery, Shanghai Changzheng Hospital, Shanghai, China
   Juxiang Chen
4. Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
   Hyo Sup Shim
5. Vanderbilt University Medical Center, Nashville, Tennessee, USA
   Juliann Chmielecki & William Pao
6. Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
   Jeffrey A Engelman, A John Iafrate & Long Phi Le

Authors

1. Zongli Zheng
   You can also search for this author inPubMed Google Scholar
2. Matthew Liebers
   You can also search for this author inPubMed Google Scholar
3. Boryana Zhelyazkova
   You can also search for this author inPubMed Google Scholar
4. Yi Cao
   You can also search for this author inPubMed Google Scholar
5. Divya Panditi
   You can also search for this author inPubMed Google Scholar
6. Kerry D Lynch
   You can also search for this author inPubMed Google Scholar
7. Juxiang Chen
   You can also search for this author inPubMed Google Scholar
8. Hayley E Robinson
   You can also search for this author inPubMed Google Scholar
9. Hyo Sup Shim
   You can also search for this author inPubMed Google Scholar
10. Juliann Chmielecki
    You can also search for this author inPubMed Google Scholar
11. William Pao
    You can also search for this author inPubMed Google Scholar
12. Jeffrey A Engelman
    You can also search for this author inPubMed Google Scholar
13. A John Iafrate
    You can also search for this author inPubMed Google Scholar
14. Long Phi Le
    You can also search for this author inPubMed Google Scholar

Contributions

Z.Z., M.L., B.Z., Y.C., D.P., K.D.L., J.C., H.E.R., H.S.S., J.C., W.P. & J.A.E. conducted the experiments; Z.Z. and L.P.L. conducted the data analyses; Z.Z. and L.P.L. wrote the manuscript; A.J.I. supervised the project.

Corresponding authors

Correspondence toA John Iafrate or Long Phi Le.

Ethics declarations

Competing interests

A provisional patent has been filed by A.J.I., L.P.L. and Z.Z. for the anchored multiplex PCR technology with the US Patent Office. A.J.I., L.P.L. and Z.Z. are equity holders in Enzymatics, Inc., a licensee of the technology.

Supplementary information

Rights and permissions

About this article

Cite this article

Zheng, Z., Liebers, M., Zhelyazkova, B. et al. Anchored multiplex PCR for targeted next-generation sequencing.Nat Med 20, 1479–1484 (2014). https://doi.org/10.1038/nm.3729

Download citation

• Received: 31 July 2013
• Accepted: 29 July 2014
• Published: 10 November 2014
• Issue Date: December 2014
• DOI: https://doi.org/10.1038/nm.3729

This article is cited by